Michael Schmertzler

Michael Schmertzler, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in PTC Therapeutics, Inc. and Hamilton Lane Inc. Between 23 September 2016 and 14 October 2026, the trades on record add up to 41 filings.

Both buying and selling appear: 2 purchases worth €2.1M, against 22 sales worth €5.8M. The net balance comes to €3.7M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 8 share grants and 2 option exercises. 2026 to date brings no purchases and 20 sales.

The newest entry dates from 16 October 2026: an open-market sale of €112k, in PTC Therapeutics, Inc. The last insider purchase was made public on 18 March 2020, 2,410 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.